PEG-based Laxative NER1006 clinical trials
How each study uses PEG-based Laxative NER1006 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 1
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses PEG-based Laxative NER1006 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Pharmacokinetic Study of PLENVU® in Healthy SubjectsCompletedPhase 1NorgineNCT03437265Written as PLENVU powder for oral solution
- Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among InpatientsStatus unknownPhase 4University of BolognaNCT04708366Written as NER1006
- Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.CompletedPhase 3NorgineNCT02273167Written as NER1006, 2-Day Split-Dosing
- Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in AdultsCompletedPhase 3NorgineNCT02254486Written as NER1006
- Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a Sodium Picosulfate and Magnesium Salt Solution Using Day Before-Only Dosing Regimen in Adults.CompletedPhase 3NorgineNCT02273141Written as NER1006, Day Before-Only Dosing
- Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening ColonoscopyCompletedPhase 2NorgineNCT01714466Written as NER1006
- Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy SubjectsCompletedPhase 1NorgineNCT01834742Written as NER1006